BHC - CIK 0000885590
The table below shows Bausch Health Companies Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.40B | $1.60B | $1.03B | -$728.00M | $1.43B | $1.11B |
| Capital expenditure | $397.00M | $337.00M | $215.00M | $218.00M | $269.00M | $302.00M |
| Investing cash flow | -$595.00M | -$454.00M | -$2.15B | -$303.00M | $409.00M | -$261.00M |
| Dividends paid | - | - | - | - | - |
Bausch Health Companies Inc. reported operating cash flow of $1.40B for fiscal year 2025. That is down 12.3% from $1.60B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $2.09B (FY 2016) to $1.40B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$742.00M | -$868.00M | $1.48B | -$474.00M | -$1.51B | -$2.29B |